Merck Spider Antivenom Benefits Outweigh Mercury Risks, FDA Says
Executive Summary
Merck's black widow spider antivenom should remain on the market because its benefits outweigh the potential risks associated with the product's mercury preservatives, FDA said Oct. 23.